Ongoing research aims to improve the specificity and sensitivity of HER2 detection methods and to develop new targeted therapies. There is also interest in understanding the mechanisms of resistance to HER2-targeted treatments and exploring combination therapies to overcome such resistance. Additionally, the role of HER2 in other types of cancer, such as gastric and lung cancers, is being actively investigated.
